Trial · NCT00549549

Participant flow16

How many started, completed or left each group, period by period.

1 to 16 of 16

Period	Milestone	Group	Participants
Overall Study	STARTED	Celecoxib 50 mg	101
Overall Study	STARTED	Celecoxib 400/200 mg	99
Overall Study	STARTED	Celecoxib 800/400 mg	99
Overall Study	STARTED	Indomethacin 50 mg	103
Overall Study	Treated	Celecoxib 50 mg	101
Overall Study	Treated	Celecoxib 400/200 mg	99
Overall Study	Treated	Celecoxib 800/400 mg	98
Overall Study	Treated	Indomethacin 50 mg	102
Overall Study	COMPLETED	Celecoxib 50 mg	77
Overall Study	COMPLETED	Celecoxib 400/200 mg	77
Overall Study	COMPLETED	Celecoxib 800/400 mg	82
Overall Study	COMPLETED	Indomethacin 50 mg	78
Overall Study	NOT COMPLETED	Celecoxib 50 mg	24
Overall Study	NOT COMPLETED	Celecoxib 400/200 mg	22
Overall Study	NOT COMPLETED	Celecoxib 800/400 mg	17
Overall Study	NOT COMPLETED	Indomethacin 50 mg	25

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00549549/flow